Amgen Inc
Current role
AMGN
James Bradner, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Bradner, M.D.
Amgen Inc reported in an 8-K filed December 14, 2023 that James Bradner, M.D. was appointed Executive Vice President, Research and Development, and Chief Scientific Officer, effective December 18, 2023.
“James Bradner, M.D., has been hired as the Company's Executive Vice President, Research and Development, and Chief Scientific Officer, an executive officer position.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Amgen Inc (AMGN)
SEC 8-K
Current2023-12-18–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Amgen Inc
Other people whose current roles at this company are on record from its filings.
- Robert Bradway CEO
- David W. Meline CFO
- Thomas Dittrich CFO
- David M. Reese, M.D. CTO
- Sean Bruich CTO
- Jonathan P. Graham General Counsel
- Linda H. Louie Chief Accounting Officer
- Matthew C. Busch Chief Accounting Officer
- Amy E. Miles Board Member
- Michael V. Drake Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.